• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

FDA grants IND clearance for Allay’s trial of post-surgical pain treatment

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jun 13, 2024 at 10:52: AM
via The US Food and Drug Administration (FDA) has granted clearance to Allay Therapeutics’ investigational new drug (IND) application to initiate a Phase IIb clinical trial of ATX101, aimed at alleviating post-surgical pain in patients undergoing total knee replacement surgery.

article source
 




Top Bottom
Back
Quote